Navigation Links
Expanded Vaccine offering for PharmaJet Needle-free Device
Date:2/14/2017

GOLDEN, Colo., Feb. 14, 2017 /PRNewswire/ -- PharmaJet® Inc., the maker of needle-free injection technology, today announced that needle-free delivery with the PharmaJet Stratis® Injector is now available for both a trivalent and quadrivalent influenza vaccine for the 2017-18 influenza season.

"The addition of a quadrivalent influenza vaccine gives healthcare providers a wider choice of vaccines that they can deliver without a needle," said Ron Lowy, PharmaJet Chairman and CEO. "PharmaJet offers the only needle-free delivery system approved by the FDA for administration of inactivated influenza vaccines.  Expanding the vaccine selection that can be used with our device is another significant step toward improving public health through expanded immunization coverage, as well as improved safety of caregivers."

Refer to Instructions for Use to ensure safe injections and to review risks.

About PharmaJet

Based in Golden, Colorado, PharmaJet's mission is worldwide acceptance of PharmaJet needle-free devices as a standard of care in the vaccine delivery market.  PharmaJet's devices are also integral in the development of multiple novel pharmaceuticals.  The innovative Stratis® device has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously.  In August 2014, the PharmaJet Stratis® device was cleared for delivery of an influenza vaccine to deliver needle-free flu shots.  The Tropis® device for intradermal injections received authorization to apply the CE Mark in May 2016.  The PharmaJet Needle-free devices are safe, fast and easy-to-use.  They eliminate needlestick injuries, needle reuse and cross contamination, and help reduce sharps waste disposal.  For more information, visit www.pharmajet.com.

CONTACT:
Nancy Lillie
Nancy.Lillie@pharmajet.com
1-888-900-4321 Option 3

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/expanded-vaccine-offering-for-pharmajet-needle-free-device-300405281.html


'/>"/>
SOURCE PharmaJet, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Profil Institute for Clinical Research, Inc. Announces Corporate Name Change to ProSciento, Inc. to Reflect Expanded Metabolism-Focused Clinical R&D Services
2. Expanded Options for Cancer Researchers with Leica Biosystems and Advanced Cell Diagnostics Automated RNA ISH Workflow with Powerful Aperio Image Analysis*
3. West Announces Expanded Contract Manufacturing Capabilities in Ireland
4. Dr. Antoine Tohmeh Enrolls First Patients in Expanded Clinical Study on Sacroiliac Joint Fusion
5. Marathon Pharmaceuticals Announces Nationwide Expanded Access Program for Patients with Duchenne Muscular Dystrophy (DMD)
6. AAIPharma Services Corp. / Cambridge Major Laboratories, Inc. Announces Expanded Capabilities and Capacity for Sterile Drug Product Manufacturing in Charleston, SC
7. Mauna Kea Technologies Announces Expanded Strategic Multiyear Partnership With Fujifilm China
8. Updated cervical cancer screening guidelines from leading ob-gyn society support expanded use of cobas HPV Test for primary screening
9. University of Maryland School of Medicine to Take Part in Expanded Medical Countermeasures Research
10. Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve
11. Caltrol And RS Calibration Services, Inc. Partner To Provide Expanded Services Solutions To Customers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2017)... June 30, 2017  AVACEN Medical (AVACEN) announced the publication of ... describes the use of its AVACEN Treatment Method to ... fibromyalgia. ... AVACEN Medical ... chronic widespread pain. It affects approximately 200 to 400 million people worldwide ...
(Date:6/27/2017)...  Therapix Biosciences Ltd. (Nasdaq: TRPX ) ... development of cannabinoid-based drugs, today announced that the Company ... New York, NY on Wednesday, ... offering (IPO) of American Depository Shares (ADSs) listed on ... Dr. Elran Haber, Ph.D., Chief Executive Officer of Therapix, ...
(Date:6/20/2017)... Netherlands and LAGUNA HILLS, Calif. ... the presentation of new data that validate the use ... risk stratify patients with multiple myeloma (MM). In a ... the European Hematology Association (EHA) in Madrid, ... value of MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology:
(Date:7/20/2017)... Minneapolis, Minnesota (PRWEB) , ... July 19, 2017 ... ... in healthcare experience, recently hiring senior healthcare project manager, Josh Christensen. As a ... the nation and looks to further its healthcare resume in the Midwest with ...
(Date:7/20/2017)... ... July 20, 2017 , ... “Lucky the Buffalo and Her Adventures”: a collection of heartwarming children’s ... Bieniek. Edward Steven Bieniek Jr. was born in Toledo, Ohio. He attended Woodward ... tech. He is married to a brilliant woman with a caring heart named Tiina, ...
(Date:7/18/2017)... ... ... an international clinical trial, led in part by a UC Davis School of Medicine expert, ... for a subgroup of patients. , In a paper just published online in the journal ... 18 countries describe the clinical benefit of using the drug ataluren for a certain group ...
(Date:7/18/2017)... ... , ... Heritage Woods of Benton, a Gardant affordable assisted living community is ... , The community, which is located at 1305 Bailey Lane in Benton, Illinois, serves ... maintain their independence. , The lunch menu will include Hawaiian chicken, meatballs and coleslaw. ...
(Date:7/17/2017)... ... July 18, 2017 , ... ... PICOPLUS 450 ps pulse width and a new published paper entitled ‘Pattern ... in tissue-mimicking phantom’ featured in Nature’s specialty journal Scientific Reports May 08, ...
Breaking Medicine News(10 mins):